These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 1352717

  • 1. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) subsequent to chemotherapy improves collection of blood stem cells for autografting in patients not eligible for bone marrow harvest.
    Haas R, Hohaus S, Egerer G, Ehrhardt R, Witt B, Hunstein W.
    Bone Marrow Transplant; 1992 Jun; 9(6):459-65. PubMed ID: 1352717
    [Abstract] [Full Text] [Related]

  • 2. Autologous blood progenitor cell transplantation in relapsed Hodgkin's disease--the role of haematopoietic growth factors.
    Haas R, Hohaus S, Ehrhardt R, Goldschmidt H, Hunstein W.
    Bone Marrow Transplant; 1993 Jun; 11 Suppl 2():30-5. PubMed ID: 8101459
    [Abstract] [Full Text] [Related]

  • 3. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells.
    Hohaus S, Martin H, Wassmann B, Egerer G, Haus U, Färber L, Burger KJ, Goldschmidt H, Hoelzer D, Haas R.
    Bone Marrow Transplant; 1998 Oct; 22(7):625-30. PubMed ID: 9818688
    [Abstract] [Full Text] [Related]

  • 4. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF.
    Hohaus S, Goldschmidt H, Ehrhardt R, Haas R.
    Exp Hematol; 1993 Apr; 21(4):508-14. PubMed ID: 7681782
    [Abstract] [Full Text] [Related]

  • 5. Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma.
    Aurlien E, Holte H, Pharo A, Kvaløy S, Jakobsen E, Smeland EB, Kvalheim G.
    Bone Marrow Transplant; 1998 May; 21(9):873-8. PubMed ID: 9613778
    [Abstract] [Full Text] [Related]

  • 6. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C, Regazzi E, Andrizzi C, Savoldo B, Garau D, Montefusco E, Vignetti M, Mandelli F, Rizzoli V, Meloni G.
    Haematologica; 1997 May; 82(3):291-6. PubMed ID: 9234574
    [Abstract] [Full Text] [Related]

  • 7. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 8. GM-CSF accelerates neutrophil recovery after autologous bone marrow transplantation for Hodgkin's disease.
    Devereaux S, Linch DC, Gribben JG, McMillan A, Patterson K, Goldstone AH.
    Bone Marrow Transplant; 1989 Jan; 4(1):49-54. PubMed ID: 2647187
    [Abstract] [Full Text] [Related]

  • 9. Utilization of recombinant human GM-CSF to enhance peripheral progenitor cell yield for autologous transplantation.
    Ho AD, Haas R, Korbling M, Dietz M, Hunstein W.
    Bone Marrow Transplant; 1991 Jan; 7 Suppl 1():13-7. PubMed ID: 1675138
    [Abstract] [Full Text] [Related]

  • 10. Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor.
    Haas R, Ho AD, Bredthauer U, Cayeux S, Egerer G, Knauf W, Hunstein W.
    Exp Hematol; 1990 Feb; 18(2):94-8. PubMed ID: 1968009
    [Abstract] [Full Text] [Related]

  • 11. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
    Weisdorf D, Miller J, Verfaillie C, Burns L, Wagner J, Blazar B, Davies S, Miller W, Hannan P, Steinbuch M, Ramsay N, McGlave P.
    Biol Blood Marrow Transplant; 1997 Oct; 3(4):217-23. PubMed ID: 9360784
    [Abstract] [Full Text] [Related]

  • 12. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [Abstract] [Full Text] [Related]

  • 13. Autologous peripheral blood stem cell transplantation after high dose therapy in patients with advanced lymphomas.
    Brice P, Marolleau JP, Dombret H, Lepage E, Baruchel A, Adam M, Miclea JM, Sitthy X, Gisselbrecht C.
    Bone Marrow Transplant; 1992 May; 9(5):337-42. PubMed ID: 1352162
    [Abstract] [Full Text] [Related]

  • 14. Collection of peripheral blood stem cells in multiple myeloma following single high-dose cyclophosphamide with and without recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF).
    Boiron JM, Marit G, Fabéres C, Cony-Makhoul P, Foures C, Ferrer AM, Cristol G, Sarrat A, Girault D, Reiffers J.
    Bone Marrow Transplant; 1993 Jul; 12(1):49-55. PubMed ID: 8104070
    [Abstract] [Full Text] [Related]

  • 15. High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma.
    Haas R, Moos M, Möhle R, Döhner H, Witt B, Goldschmidt H, Murea S, Flentje M, Wannenmacher M, Hunstein W.
    Bone Marrow Transplant; 1996 Feb; 17(2):149-55. PubMed ID: 8640159
    [Abstract] [Full Text] [Related]

  • 16. High-dose chemotherapy and autologous peripheral blood progenitor cell transplant for the treatment of Hodgkin's disease.
    Weaver CH, Schwartzberg L, Li W, Hazelton B, West W.
    Bone Marrow Transplant; 1996 May; 17(5):715-21. PubMed ID: 8733687
    [Abstract] [Full Text] [Related]

  • 17. Granulocyte-macrophage colony-stimulating factor accelerates hematopoietic recovery after autologous bone marrow or peripheral blood progenitor cell transplantation and high-dose chemotherapy for lymphoma.
    Colombat P, Delain M, Desbois I, Domenech J, Binet C, Tabah I, Lamagnere JP, Linassier C.
    Bone Marrow Transplant; 1996 Aug; 18(2):293-9. PubMed ID: 8864437
    [Abstract] [Full Text] [Related]

  • 18. A mononuclear cell dose of 3 x 10(8)/kg predicts early multilineage recovery in patients with malignant lymphoma treated with carmustine, etoposide, Ara-C and melphalan (BEAM) and peripheral blood progenitor cell transplantation.
    Smith RJ, Sweetenham JW.
    Exp Hematol; 1995 Dec; 23(14):1581-8. PubMed ID: 8542950
    [Abstract] [Full Text] [Related]

  • 19. [High-dose chemoradiotherapy combined with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) followed by autologous peripheral blood stem cell transplantation (PBSCT) in a case of refractory acute myelogenous leukemia (AML)].
    Tanosaki R, Okamoto S, Takahashi S, Inoue T, Kikuno K, Aoki Y, Takada M, Irie S, Shimane M, Tojo A.
    Rinsho Ketsueki; 1993 Aug; 34(8):946-51. PubMed ID: 8105115
    [Abstract] [Full Text] [Related]

  • 20. Role of recombinant human granulocyte-macrophage colony stimulating factor for large scale collection of peripheral blood stem cells for autologous transplantation.
    Ravagnani F, Bregni M, Siena S, Sciorelli G, Gianni AM, Pellegris G.
    Haematologica; 1990 Aug; 75 Suppl 1():22-5. PubMed ID: 2190882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.